Logo image of DEX.DE

DELTICOM AG (DEX.DE) Stock Fundamental Analysis

Europe - FRA:DEX - DE0005146807 - Common Stock

2.29 EUR
0 (0%)
Last: 9/16/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to DEX. DEX was compared to 53 industry peers in the Specialty Retail industry. DEX has a medium profitability rating, but doesn't score so well on its financial health evaluation. DEX has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

DEX had positive earnings in the past year.
In the past year DEX had a positive cash flow from operations.
Each year in the past 5 years DEX has been profitable.
DEX had a positive operating cash flow in 4 of the past 5 years.
DEX.DE Yearly Net Income VS EBIT VS OCF VS FCFDEX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

1.2 Ratios

The Return On Assets of DEX (1.66%) is comparable to the rest of the industry.
DEX has a better Return On Equity (8.08%) than 67.92% of its industry peers.
DEX's Return On Invested Capital of 10.27% is amongst the best of the industry. DEX outperforms 81.13% of its industry peers.
DEX had an Average Return On Invested Capital over the past 3 years of 9.76%. This is in line with the industry average of 8.43%.
The 3 year average ROIC (9.76%) for DEX is below the current ROIC(10.27%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.66%
ROE 8.08%
ROIC 10.27%
ROA(3y)2.45%
ROA(5y)2.76%
ROE(3y)10.57%
ROE(5y)19.74%
ROIC(3y)9.76%
ROIC(5y)11.86%
DEX.DE Yearly ROA, ROE, ROICDEX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

DEX's Profit Margin of 0.80% is in line compared to the rest of the industry. DEX outperforms 47.17% of its industry peers.
In the last couple of years the Profit Margin of DEX has declined.
DEX has a Operating Margin (3.22%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of DEX has grown nicely.
With a Gross Margin value of 29.25%, DEX is not doing good in the industry: 62.26% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of DEX has grown nicely.
Industry RankSector Rank
OM 3.22%
PM (TTM) 0.8%
GM 29.25%
OM growth 3Y8.35%
OM growth 5YN/A
PM growth 3Y-10.2%
PM growth 5YN/A
GM growth 3Y4.67%
GM growth 5Y2.36%
DEX.DE Yearly Profit, Operating, Gross MarginsDEX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so DEX is creating value.
The number of shares outstanding for DEX has been reduced compared to 1 year ago.
Compared to 5 years ago, DEX has more shares outstanding
Compared to 1 year ago, DEX has a worse debt to assets ratio.
DEX.DE Yearly Shares OutstandingDEX.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
DEX.DE Yearly Total Debt VS Total AssetsDEX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 2.42 indicates that DEX is not a great score, but indicates only limited risk for bankruptcy at the moment.
DEX has a Altman-Z score of 2.42. This is in the better half of the industry: DEX outperforms 62.26% of its industry peers.
The Debt to FCF ratio of DEX is 4.74, which is a neutral value as it means it would take DEX, 4.74 years of fcf income to pay off all of its debts.
DEX has a better Debt to FCF ratio (4.74) than 67.92% of its industry peers.
DEX has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.10, DEX is not doing good in the industry: 69.81% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 4.74
Altman-Z 2.42
ROIC/WACC2.18
WACC4.7%
DEX.DE Yearly LT Debt VS Equity VS FCFDEX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

A Current Ratio of 0.88 indicates that DEX may have some problems paying its short term obligations.
DEX's Current ratio of 0.88 is on the low side compared to the rest of the industry. DEX is outperformed by 73.58% of its industry peers.
DEX has a Quick Ratio of 0.88. This is a bad value and indicates that DEX is not financially healthy enough and could expect problems in meeting its short term obligations.
DEX has a worse Quick ratio (0.30) than 77.36% of its industry peers.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.3
DEX.DE Yearly Current Assets VS Current LiabilitesDEX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

3

3. Growth

3.1 Past

DEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -49.58%.
DEX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -17.71% yearly.
DEX shows a small growth in Revenue. In the last year, the Revenue has grown by 0.84%.
The Revenue has been decreasing by -5.23% on average over the past years.
EPS 1Y (TTM)-49.58%
EPS 3Y-17.71%
EPS 5YN/A
EPS Q2Q%-3004.88%
Revenue 1Y (TTM)0.84%
Revenue growth 3Y-6.18%
Revenue growth 5Y-5.23%
Sales Q2Q%11.97%

3.2 Future

The Earnings Per Share is expected to grow by 15.77% on average over the next years. This is quite good.
DEX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.57% yearly.
EPS Next Y-4.6%
EPS Next 2Y14.97%
EPS Next 3Y15.77%
EPS Next 5YN/A
Revenue Next Year4.43%
Revenue Next 2Y3.82%
Revenue Next 3Y3.5%
Revenue Next 5Y3.57%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DEX.DE Yearly Revenue VS EstimatesDEX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M
DEX.DE Yearly EPS VS EstimatesDEX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 0.2 0.3 0.4

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.48, the valuation of DEX can be described as reasonable.
Based on the Price/Earnings ratio, DEX is valued cheaper than 88.68% of the companies in the same industry.
DEX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.20.
A Price/Forward Earnings ratio of 5.91 indicates a rather cheap valuation of DEX.
DEX's Price/Forward Earnings ratio is rather cheap when compared to the industry. DEX is cheaper than 90.57% of the companies in the same industry.
DEX is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.71, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.48
Fwd PE 5.91
DEX.DE Price Earnings VS Forward Price EarningsDEX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

DEX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. DEX is cheaper than 83.02% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, DEX is valued cheaper than 96.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.91
EV/EBITDA 4.4
DEX.DE Per share dataDEX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

DEX has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as DEX's earnings are expected to grow with 15.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.97%
EPS Next 3Y15.77%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.19%, DEX is a good candidate for dividend investing.
DEX's Dividend Yield is rather good when compared to the industry average which is at 3.39. DEX pays more dividend than 96.23% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, DEX pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.19%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
DEX.DE Yearly Dividends per shareDEX.DE Yearly Dividends per shareYearly Dividends per share 2025 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

DP0%
EPS Next 2Y14.97%
EPS Next 3Y15.77%
DEX.DE Yearly Income VS Free CF VS DividendDEX.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

DELTICOM AG

FRA:DEX (9/16/2025, 7:00:00 PM)

2.29

0 (0%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-14 2025-08-14
Earnings (Next)11-13 2025-11-13
Inst Owners22.96%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap33.96M
Analysts80
Price Target3.81 (66.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.19%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.61%
PT rev (3m)-2.61%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-16.16%
EPS NY rev (3m)-16.16%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.33%
Revenue NY rev (3m)0.33%
Valuation
Industry RankSector Rank
PE 8.48
Fwd PE 5.91
P/S 0.07
P/FCF 1.91
P/OCF 1.56
P/B 0.68
P/tB 2.62
EV/EBITDA 4.4
EPS(TTM)0.27
EY11.79%
EPS(NY)0.39
Fwd EY16.91%
FCF(TTM)1.2
FCFY52.28%
OCF(TTM)1.47
OCFY64.24%
SpS34.19
BVpS3.37
TBVpS0.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.66%
ROE 8.08%
ROCE 15.55%
ROIC 10.27%
ROICexc 10.62%
ROICexgc 16.72%
OM 3.22%
PM (TTM) 0.8%
GM 29.25%
FCFM 3.5%
ROA(3y)2.45%
ROA(5y)2.76%
ROE(3y)10.57%
ROE(5y)19.74%
ROIC(3y)9.76%
ROIC(5y)11.86%
ROICexc(3y)10.32%
ROICexc(5y)12.68%
ROICexgc(3y)16.92%
ROICexgc(5y)26.93%
ROCE(3y)15.21%
ROCE(5y)18.21%
ROICexcg growth 3Y-17.38%
ROICexcg growth 5YN/A
ROICexc growth 3Y-10.03%
ROICexc growth 5YN/A
OM growth 3Y8.35%
OM growth 5YN/A
PM growth 3Y-10.2%
PM growth 5YN/A
GM growth 3Y4.67%
GM growth 5Y2.36%
F-Score5
Asset Turnover2.08
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 4.74
Debt/EBITDA 2.1
Cap/Depr 41.59%
Cap/Sales 0.8%
Interest Coverage 5.73
Cash Conversion 83.68%
Profit Quality 439.92%
Current Ratio 0.88
Quick Ratio 0.3
Altman-Z 2.42
F-Score5
WACC4.7%
ROIC/WACC2.18
Cap/Depr(3y)47.93%
Cap/Depr(5y)34.33%
Cap/Sales(3y)0.92%
Cap/Sales(5y)0.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.58%
EPS 3Y-17.71%
EPS 5YN/A
EPS Q2Q%-3004.88%
EPS Next Y-4.6%
EPS Next 2Y14.97%
EPS Next 3Y15.77%
EPS Next 5YN/A
Revenue 1Y (TTM)0.84%
Revenue growth 3Y-6.18%
Revenue growth 5Y-5.23%
Sales Q2Q%11.97%
Revenue Next Year4.43%
Revenue Next 2Y3.82%
Revenue Next 3Y3.5%
Revenue Next 5Y3.57%
EBIT growth 1Y0.39%
EBIT growth 3Y1.65%
EBIT growth 5YN/A
EBIT Next Year127.04%
EBIT Next 3Y40.26%
EBIT Next 5YN/A
FCF growth 1Y1378.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y355.54%
OCF growth 3Y-39.47%
OCF growth 5YN/A